Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00033020 · ClinicalTrials.gov registry record · Phase 3

Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics. - 1

A Phase 3 study, sponsored by Johns Hopkins University.

Completed
Registry status
Phase 3
Development phase
390
Enrollment target

NCT00033020: Completed Phase 3 study, sponsored by Johns Hopkins University.

NCT00033020 is a Phase 3 study that has completed, run by Johns Hopkins University. The registered enrollment target is 390 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (49% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00033020, a Phase 3 study, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
Phase 3
Development phase
390 participants
Enrollment target

Study Summary

The purpose of this study is to test the utilization of incentive values (considerably lower than those typically used in research clinics) to motivate clients to attend treatment and initiate and sustain abstinence.

Interventions

  • BEHAVIORAL Behavior Therapy

Trial Details

FieldValue
Enrollment Target 390 participants
Start Date 2001-04
Est. Completion 2003-02
Phase Phase 3
Johns Hopkins University

1,448 total trials

What the finished NCT00033020 record still lists

NCT00033020 is an interventional study that assigns participants to a tested intervention. The registered 390 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (49% lower).

The record links to 0 conditions, and to 1 intervention - of which Behavior Therapy is the first listed.

NCT00033020 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00033020 about?

NCT00033020 is a clinical study titled "Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics. - 1". The purpose of this study is to test the utilization of incentive values (considerably lower than those typically used in research clinics) to motivate clients to attend treatment and initiate and sustain abstinence.

What is the current status of trial NCT00033020?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 390 participants. The study started on 2001-04. Estimated completion is 2003-02.

What interventions are being tested in trial NCT00033020?

The interventions under investigation include: Behavior Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT00033020?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00033020's enrollment target sits among peer trials

390 968th of 2000 higher than 1,029 of 2,000 other Phase 3 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00397111 · 390 participants

    Development of Magnetic Resonance Imaging Techniques for Studying Mood and Anxiety Disorders

  • NCT05335928 · 390 participants · Phase 3

    Abatacept in Immune Checkpoint Inhibitor Myocarditis

  • NCT05445960 · 390 participants · NA

    Correlation Between Intraoperative Tourniquet Use and Limb pH, Functional Measures and Patient-reported Outcomes After Ankle Fracture Surgery

  • NCT05997615 · 390 participants · Phase 1

    Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00033020, the US trial registry maintained by the National Library of Medicine. NCT00033020 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.